LILRA4
Leukocyte immunoglobulin-like receptor subfamily A member 4
Also known as: CD85g, ILT7, LIRA4_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- P59901
- Gene
- LILRA4
- Ensembl
- ENSG00000239961
- Chromosome
- 19
- Canonical length
- 499 aa
- Protein class
- CD markers, Predicted membrane proteins
OverviewNCBI Gene
This gene encodes an immunoglobulin-like cell surface protein that is expressed predominantly on plasmacytoid dendritic cells (PDCs) and modulates the function of these cells in the immune response. Expression of this gene is downregulated by interleukin 3 (IL3). This gene is one of a cluster of highly related genes located at chromosomal region 19q13.4. [provided by RefSeq, Jan 2015]
Canonical amino-acid sequenceUniProt
499 residues, UniProt reviewed canonical sequence.
>P59901|LILRA4
1 MTLILTSLLF FGLSLGPRTR VQAENLLKPI LWAEPGPVIT WHNPVTIWCQ GTLEAQGYRL
61 DKEGNSMSRH ILKTLESENK VKLSIPSMMW EHAGRYHCYY QSPAGWSEPS DPLELVVTAY
121 SRPTLSALPS PVVTSGVNVT LRCASRLGLG RFTLIEEGDH RLSWTLNSHQ HNHGKFQALF
181 PMGPLTFSNR GTFRCYGYEN NTPYVWSEPS DPLQLLVSGV SRKPSLLTLQ GPVVTPGENL
241 TLQCGSDVGY IRYTLYKEGA DGLPQRPGRQ PQAGLSQANF TLSPVSRSYG GQYRCYGAHN
301 VSSEWSAPSD PLDILIAGQI SDRPSLSVQP GPTVTSGEKV TLLCQSWDPM FTFLLTKEGA
361 AHPPLRLRSM YGAHKYQAEF PMSPVTSAHA GTYRCYGSRS SNPYLLSHPS EPLELVVSGA
421 TETLNPAQKK SDSKTAPHLQ DYTVENLIRM GVAGLVLLFL GILLFEAQHS QRSPPRCSQE
481 ANSRKDNAPF RVVEPWEQILocalizationUniProt · AlphaFold · HPA
Whether an antibody against LILRA4 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Cell surface
- Secreted
- No
- Transmembrane segments
- 1
- Mean surface accessibility (rSASA)
- 0.36
- Highest tissue expression
- 10 nTPM
Expression across tissuesHPA
Tissue
- spleen: 10 nTPM
- spinal cord: 4.3 nTPM
- midbrain: 2.5 nTPM
- tonsil: 2.4 nTPM
- small intestine: 1.2 nTPM
- amygdala: 0.9 nTPM
Single-cell type
- pdcs: 79 nCPM
- microglia: 6.1 nCPM
- thymocytes: 4.2 nCPM
- b-cells: 0.7 nCPM
- macrophages: 0.5 nCPM
- cdc: 0.2 nCPM
Immune cell
- plasmacytoid DC: 176 nTPM
- memory B-cell: 8.4 nTPM
- naive B-cell: 3.9 nTPM
- myeloid DC: 1.1 nTPM
- total PBMC: 1.1 nTPM
- NK-cell: 0.4 nTPM
Brain region
- medulla oblongata: 1.6 nTPM
- white matter: 1.6 nTPM
- pons: 1.5 nTPM
- thalamus: 1.2 nTPM
- cerebellum: 0.8 nTPM
- cerebral cortex: 0.8 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.45
- gnomAD pLI
- 0
- gnomAD missense Z
- -0.5
- DepMap mean gene effect
- -0.04
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 3% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- cytokine-mediated signaling pathway
- Fc-epsilon receptor signaling pathway
- immune response-regulating signaling pathway
- innate immune response
- negative regulation of interferon-alpha production
- negative regulation of toll-like receptor 9 signaling pathway
- negative regulation of tumor necrosis factor production
- negative regulation of toll-like receptor 7 signaling pathway
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
- Immunoglobulin subtype 2
- Immunoglobulin domain subtype
- Immunoglobulin-like domain
- Immunoglobulin-like beta-sandwich domain
- Immunoglobulin-like fold
- Alpha-1B-glycoprotein/leukocyte immunoglobulin-like receptor
- Immunoglobulin-like domain superfamily
- Immunoglobulin-like Receptors in Immune Regulation
- Immunoglobulin domain
- Immunoglobulin domain
- Immunoglobulin domain
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of LILRA4 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads LILRA4 as an antibody target. Whether an autoantibody or antibody against LILRA4 could matter depends on whether native LILRA4 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
LILRA4 is annotated at the cell surface, where native LILRA4 is exposed to circulating antibodies and is a prime autoantibody target that could block, deplete, or overstimulate it.
Annotation status
The present source text does not explicitly label LILRA4 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...